Question 1

What is the price of Rapport Therapeutics, Inc. Common Stock stock today?

Accepted Answer

The current price of RAPP is $37.07 USD, it has decreased by -2.32% in the past 24 hours.

Question 2

Is Rapport Therapeutics, Inc. Common Stock stock price growing?

Accepted Answer

Rapport Therapeutics, Inc. Common Stock stock has dropped by -3.54% compared to the previous week. The monthly change is a -6.65% drop. Over the last year, Rapport Therapeutics, Inc. Common Stock has showed a +263.79% increase.

Question 3

How volatile is RAPP?

Accepted Answer

RAPP has a beta of 0.82, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Question 4

What is Rapport Therapeutics, Inc. Common Stock market cap?

Accepted Answer

Today Rapport Therapeutics, Inc. Common Stock has a market capitalization of $1.4B.

Question 5

What are RAPP highest and lowest price in the last year?

Accepted Answer

RAPP highest price in the last year was $42.27 USD, and its lowest price was $7.73 USD.

Question 6

Is RAPP overvalued or undervalued?

Accepted Answer

RAPP currently has a P/E ratio of -16.32. Relative to the sector average of 24.20, this suggests the stock may be undervalued.

A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

Question 7

What is Rapport Therapeutics, Inc. Common Stock revenue for the last quarter?

Accepted Answer

Rapport Therapeutics, Inc. Common Stock revenue for the last quarter amounts to $0 USD.

Question 8

What is Rapport Therapeutics, Inc. Common Stock net income for the last quarter?

Accepted Answer

Rapport Therapeutics, Inc. Common Stock net income for the last quarter amounts to $-111483000 USD.

Question 9

How many employees does Rapport Therapeutics, Inc. Common Stock have?

Accepted Answer

Rapport Therapeutics, Inc. Common Stock currently has 69 employees.

Question 10

How can I buy Rapport Therapeutics, Inc. Common Stock stock?

Accepted Answer

Investors in Latin America can buy foreign stocks through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Question 11

Can I buy fractional shares of RAPP?

Accepted Answer

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Question 12

Does buying RAPP protect my money against local inflation?

Accepted Answer

Many investors in Latin America buy international stocks like RAPP to protect their purchasing power. Because RAPP is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Question 13

Do I need a foreign bank account or a Visa to buy RAPP shares?

Accepted Answer

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Question 14

Is RAPP a suitable investment for my portfolio?

Accepted Answer

An investment in RAPP should be evaluated within the broader context of your specific financial objectives, risk appetite, and long-term asset-allocation strategy. A prudent assessment typically centers on three fundamental pillars:

• Fundamental Valuation & Regional Growth Drivers: Analyze the stock's price-to-earnings (P/E) ratio and revenue growth relative to its specific market.
• Multi-Currency Risk Management & Hedging: For Latin American investors, the currency of denomination is as critical as the asset itself. You must determine if holding RAPP serves as a necessary hedge against local currency volatility.
• Regulatory & Tax Optimization: Evaluate the structural efficiency of the investment, considering withholding taxes and estate tax thresholds applicable in your jurisdiction.

Disclaimer: This analysis is provided for informational purposes only and does not constitute financial, legal, or tax advice. We recommend consulting with a certified professional in your jurisdiction.

Rapport Therapeutics, Inc. Common Stock

Price chart

Available on

Rapport Therapeutics, Inc. Common Stock

Price chart

Available on